Product Name:Human Melanoma- derived growth regulatory protein, MIA ELISA KITPacking:96T
Catalog No.:ELI-06027h
Gene Name:MIA
Detect Range:0.156-10 ng/mL
Sensitivity:0.078ng/mL
Target Protein Name:Melanoma-derived growth regulatory protein(MIA
Alternative Name:MIA,Melanoma-derived growth regulatory protein(MIASample type:serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA type:Sandwich ELISA KitProduct Description:Human Melanoma- derived growth regulatory protein, MIA ELISA KIT allows for the in vitro quantitative determination of Melanoma-derived growth regulatory protein(MIA concentrations in serum, plasma, tissue homogenates, cell culture supernates or other biological fluids.
ELISA Test Principle:The microtiter plate provided in Human Melanoma- derived growth regulatory protein, MIA ELISA KIT has been pre-coated with an Melanoma-derived growth regulatory protein(MIA antibody specific to Melanoma-derived growth regulatory protein(MIA .Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody preparation specific for Melanoma-derived growth regulatory protein(MIA and then avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain Melanoma-derived growth regulatory protein(MIA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm.The concentration of Melanoma-derived growth regulatory protein(MIA in the samples is then determined by comparing the O.D. of the samples to the standard curve.
NOTE:FOR RESEARCH USE ONLY; NOT FOR THERAPEUTIC OR DIAGNOSTIC APPLICATIONS! PLEASE READ ENTIRE PROCEDURE!
The quality assurance and experimental performance of this biological reagent are rigorously optimized and standardized according to its specific technical pathway: Double Antibody Sandwich Method (双抗体夹心法). This ensures maximum reproducibility across clinical research and scientific workflows.